Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Barbara Van Hare"'
Autor:
Andrew L Hong, Yuen-Yi Tseng, Jeremiah A Wala, Won-Jun Kim, Bryan D Kynnap, Mihir B Doshi, Guillaume Kugener, Gabriel J Sandoval, Thomas P Howard, Ji Li, Xiaoping Yang, Michelle Tillgren, Mahmhoud Ghandi, Abeer Sayeed, Rebecca Deasy, Abigail Ward, Brian McSteen, Katherine M Labella, Paula Keskula, Adam Tracy, Cora Connor, Catherine M Clinton, Alanna J Church, Brian D Crompton, Katherine A Janeway, Barbara Van Hare, David Sandak, Ole Gjoerup, Pratiti Bandopadhayay, Paul A Clemons, Stuart L Schreiber, David E Root, Prafulla C Gokhale, Susan N Chi, Elizabeth A Mullen, Charles WM Roberts, Cigall Kadoch, Rameen Beroukhim, Keith L Ligon, Jesse S Boehm, William C Hahn
Publikováno v:
eLife, Vol 8 (2019)
Renal medullary carcinoma (RMC) is a rare and deadly kidney cancer in patients of African descent with sickle cell trait. We have developed faithful patient-derived RMC models and using whole-genome sequencing, we identified loss-of-function intronic
Externí odkaz:
https://doaj.org/article/ea9c3a1d96864bb8bbdbc626e575f019
Autor:
Kathryn Cebula, Grace Johnson, Mushriq Al-Jazrawe, Irene Lernman, Barbara Van Hare, Carmen Rios, Moony Tseng, Jesse Boehm
Publikováno v:
Cancer Research. 82:697-697
Precision cancer medicine is based on the ability to predict the dependencies of a given tumor from its molecular makeup. Despite successes in multiple common cancers, such prediction remains challenging for the majority of rare and understudied tumo
Autor:
Adel Attari, Madison Liistro, Barbara Van Hare, Jennifer Chan, Emma Coleman, Tim Heffernan, Bianca Amador, Matthew Meyerson, Jesse Boehm, William Sellers, Yuen-Yi (Moony) Tseng
Publikováno v:
Cancer Research. 82:197-197
The Broad Cancer Cell Line Factory (CCLF) aims to increase the number and representation of in vitro/ex vivo cell models for common and rare cancer types. Neuroendocrine tumor (NET) cell model derivation is one of the CCLFs focus because it lacks wel
Autor:
Abeer Sayeed, Xiaoping Yang, Elizabeth Mullen, Gabriel J. Sandoval, Pratiti Bandopadhayay, Michelle Tillgren, Andrew L. Hong, William C. Hahn, Abigail Ward, Katherine Labella, Brian McSteen, Rameen Beroukhim, Adam Tracy, Mihir B. Doshi, Charles W. M. Roberts, Prafulla C. Gokhale, Won Jun Kim, Jesse S. Boehm, Mahmhoud Ghandi, Stuart L. Schreiber, David E. Root, Ji Li, Susan N. Chi, Jeremiah Wala, Ole Gjoerup, Cora Connor, Paul A. Clemons, Katherine A. Janeway, Thomas P. Howard, Alanna J. Church, Bryan D. Kynnap, David Sandak, Cigall Kadoch, Keith L. Ligon, Brian D. Crompton, Paula Keskula, Yuen-Yi Tseng, Rebecca Deasy, Guillaume Kugener, Barbara Van Hare, Catherine Clinton
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5b44f99bc17d54121519cb0d6df6c5b3
https://doi.org/10.7554/elife.44161.051
https://doi.org/10.7554/elife.44161.051
Autor:
Adam J. Bass, Grace Johnson, Priya Chatterji, Yuen-Yi Tseng, Rebecca Deasy, Mushriq AI-Jazrawe, Francisca Vasquez, Jesse S. Boehm, Paula Keskula, Barbara Van Hare, Keith L. Ligon, David Sandak, Andrew L. Hong
Publikováno v:
Cancer Research. 80:3453-3453
Precision cancer medicine is based on the ability to predict the dependencies of a given tumor from its molecular makeup. Despite successes in multiple common cancers, such prediction remains challenging for the majority of rare and understudied tumo
Autor:
Adam J. Bass, Jesse S. Boehm, Andrew L. Hong, David Sandak, Paula Keskula, Barbara Van Hare, Keith L. Ligon, Priya Chatterji, Francisca Vazquez, Yuen-Yi Tseng, Rebecca Deasy
Publikováno v:
Cancer Research. 80:PR09-PR09
Precision cancer medicine is based on the ability to predict the dependencies of a given tumor from its molecular makeup. Despite successes in multiple common cancers, such prediction remains challenging for the majority of rare and understudied tumo